Provider
QP63-22 MHCP Pharmacy Benefit Update – New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Ryplazim® (plasminogen, human-tvmh)
Program effective Date: Jul 27, 2022
Program effective Date: Jul 27, 2022
Program effective Date: Jul 13, 2022
Program effective Date: Jul 13, 2022
Program effective Date: Jul 13, 2022
Program effective Date: Jul 13, 2022
Program effective Date: Jul 13, 2022
Program effective Date: Jul 13, 2022
Program effective Date: Jul 01, 2022
Program effective Date: Jul 01, 2022
Program effective Date: Jul 01, 2022